HGF are Silver Sponsors of LSPN Europe 2025

Event date: 4th November 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire life cycle of innovation.

The event brings together over 150 senior IP professionals and 20+ expert speakers for a full day of high-level discussions, case studies, and networking opportunities, all designed to explore the latest developments in patent management across the life sciences sector.

As part of this year’s programme, Rachel Fetches, Partner & Head of Law at HGF, will be speaking at a strategic panel session entitled “Behind the Scenes of Big Ticket Litigation: Lessons from the Courts.” The session will examine the dynamics behind major recent disputes and settlements, including the Abbott–Dexcom settlement at the start of 2025, and offer insight into how leading life sciences companies are adapting their IP litigation strategies in a changing European enforcement environment.

Key themes include:

• The UPC’s growing influence on European patent litigation

• Case study: Strategic drivers behind the Abbott–Dexcom settlement

• Biosimilar litigation trends and post-UPC defensive strategies

• mRNA patent enforcement and emerging case law

• Standard-essential patents (SEPs): FRAND obligations and licensing approaches

• Choosing between national courts and the UPC system

Balvinder Matharu, Partner & Patent Attorney, Alex Wood, Senior European Patent Attorney, and Amy Shaw, Patent Attorney, will also be attending the event and are looking forward to joining peers and clients to exchange insights on protecting innovation in the life sciences sector.

With its unique mix of in-house, pharma, biotech, and medtech professionals, LSPN Europe 2025 provides an ideal platform to connect with industry leaders, gain fresh perspectives, and engage in meaningful discussions that shape the future of IP strategy in life sciences.

Find out more below.